Please contact us with any questions or if you'd like to explore your legal rights
Name 
Email Address 
Phone 
Message 
Pharmaceutical Drug Litigation
Although medications can provide positive health and lifestyle changes, medications carry their own health risks. Both healthcare providers and patients need and deserve to be properly informed of these risks.

Products can change from life giving to life taking when pharmaceutical and biological companies:
  • fail to properly study their products both pre- and post-FDA approval,
  • fail to properly analyze study results,
  • fail to properly monitor, report and/or analyze adverse events,
  • fail to properly market products, or
  • fail to properly educate healthcare providers and patients about benefits and risks of these products.
Proving such negligence requires experience, creativity and adequate resources. But the end result can change the way the industry practices, and most importantly can save lives.

Motley Rice lawyers have represented individuals that have been injured by a variety of pharmaceutical drugs. Our lawyers have many years of experience litigating cases against manufacturers of defective product including members of the pharmaceutical industry.

An example of Motley Rice's pharmaceutical drug litigation experience is the representation of more than 2,000 cases involving serious health problems stemming from the use of the diet drugs commonly known as Fen-Phen and Redux. The combination of some diet drugs has led to heart valve damage, stroke and heart attacks. We also represent clients that have been victims of medical prescription error.

Motley Rice lawyers and staff represent individuals who were injured through the use of pharmaceutical drugs and provide our clients with up-to-date information about the drug and their legal options.
The Law Firm of Motley Rice LLC Legal services for people harmed by pharmaceutical and biological products
Pharmaceutical News
VIOXX® SETTLEMENT ANNOUNCED

The law firms that comprise the Executive Committee of the Plaintiffs' Steering Committee of the federal multidistrict VIOXX litigation, as well as representatives of plaintiffs' counsel in state coordinated proceedings, have reached an agreement to resolve U.S. products liability VIOXX claims already filed against the company. Merck has set aside $4.85 billion to pay claims of U.S. plaintiffs who suffered myocardial infarctions or ischemic strokes.

click here to learn more
Renewing criticism over drug ads
Study says TV commercials oversell and undereducate

January 30, 2007
The Law Firm of Motley Rice LLC Legal services for people harmed by pharmaceutical and biological products If you are interested in discussing a potential case, please contact us via this Web site or contact Fred Thompson at 1-800-768-4026.